These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32853464)

  • 21. The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer.
    Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
    J Immunother Cancer; 2019 Apr; 7(1):98. PubMed ID: 30944026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach.
    Goto T; Hirotsu Y; Amemiya K; Mochizuki H; Omata M
    Cancers (Basel); 2018 Jun; 10(7):. PubMed ID: 29932159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
    Song D; Wang X
    J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clonal expression biomarker associates with lung cancer mortality.
    Biswas D; Birkbak NJ; Rosenthal R; Hiley CT; Lim EL; Papp K; Boeing S; Krzystanek M; Djureinovic D; La Fleur L; Greco M; Döme B; Fillinger J; Brunnström H; Wu Y; Moore DA; Skrzypski M; Abbosh C; Litchfield K; Al Bakir M; Watkins TBK; Veeriah S; Wilson GA; Jamal-Hanjani M; Moldvay J; Botling J; Chinnaiyan AM; Micke P; Hackshaw A; Bartek J; Csabai I; Szallasi Z; Herrero J; McGranahan N; Swanton C;
    Nat Med; 2019 Oct; 25(10):1540-1548. PubMed ID: 31591602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
    Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
    PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
    Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
    Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.
    Quek K; Li J; Estecio M; Zhang J; Fujimoto J; Roarty E; Little L; Chow CW; Song X; Behrens C; Chen T; William WN; Swisher S; Heymach J; Wistuba I; Zhang J; Futreal A; Zhang J
    Oncotarget; 2017 Mar; 8(13):21994-22002. PubMed ID: 28423542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
    Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
    Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational Heterogeneity in
    Gausachs M; Borras E; Chang K; Gonzalez S; Azuara D; Delgado Amador A; Lopez-Doriga A; San Lucas FA; Sanjuan X; Paules MJ; Taggart MW; Davies GE; Ehli EA; Fowler J; Moreno V; Pineda M; You YN; Lynch PM; Lazaro C; Navin NE; Scheet PA; Hawk ET; Capella G; Vilar E
    Clin Cancer Res; 2017 Oct; 23(19):5936-5947. PubMed ID: 28645942
    [No Abstract]   [Full Text] [Related]  

  • 31. Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors.
    Harada T; Yamamoto E; Yamano HO; Aoki H; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Tanaka Y; Yoshida Y; Eizuka M; Yorozu A; Sudo G; Kitajima H; Niinuma T; Kai M; Sasaki Y; Tokino T; Sugai T; Nakase H; Suzuki H
    J Gastroenterol; 2018 Dec; 53(12):1241-1252. PubMed ID: 29948303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally.
    Wolf Y; Samuels Y
    Clin Cancer Res; 2022 Jul; 28(14):2994-3001. PubMed ID: 35380639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis.
    Yu T; Gao X; Zheng Z; Zhao X; Zhang S; Li C; Liu G
    Front Oncol; 2021; 11():744064. PubMed ID: 34722299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
    Park Y; Lim S; Nam JW; Kim S
    Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualizing Human Colorectal Cancer Intratumor Heterogeneity with Phylogeography.
    Shibata D
    iScience; 2020 Jul; 23(7):101304. PubMed ID: 32623333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
    Stanta G; Bonin S
    Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma.
    Reinartz R; Wang S; Kebir S; Silver DJ; Wieland A; Zheng T; Küpper M; Rauschenbach L; Fimmers R; Shepherd TM; Trageser D; Till A; Schäfer N; Glas M; Hillmer AM; Cichon S; Smith AA; Pietsch T; Liu Y; Reynolds BA; Yachnis A; Pincus DW; Simon M; Brüstle O; Steindler DA; Scheffler B
    Clin Cancer Res; 2017 Jan; 23(2):562-574. PubMed ID: 27521447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Big Bang model of human colorectal tumor growth.
    Sottoriva A; Kang H; Ma Z; Graham TA; Salomon MP; Zhao J; Marjoram P; Siegmund K; Press MF; Shibata D; Curtis C
    Nat Genet; 2015 Mar; 47(3):209-16. PubMed ID: 25665006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.